Literature DB >> 8615344

Social and economic effects of body weight in the United States.

A M Wolf1, G A Colditz.   

Abstract

Given that overweight is clearly associated with increased risk of many major chronic diseases, the United States could have saved approximately $45.8 billion or 6.8% of health care expenditures in 1990 alone if obesity were prevented. The question then arises, economically and socially, what is a healthy body weight? Using a prevalence-based approach to cost of illness, we estimated the economic costs (1993 dollars) associated with illness at different strata of body mass indexes (BMIs, in kg/m2) and varying increments of weight gain to address the questions: At what body weight do we initiate preventive services? What are the direct costs associated with weight gain? Second, using the 1988 National Health Interview Survey (NHIS), we evaluated the marginal increase in certain social indexes reflective of functional impairment and morbidity (ie, restricted-activity days, bed days, and work-loss days) as well as physician visits associated with different strata of BMI. With respect to economic and social indexes, a healthy body weight appears to be a BMI < 25, and weight gain should be kept to < 5 kg throughout a lifetime.

Entities:  

Mesh:

Year:  1996        PMID: 8615344     DOI: 10.1093/ajcn/63.3.466

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

1.  Metalloproteases and adipogenesis: a weighty subject.

Authors:  Jennifer Lilla; Dominique Stickens; Zena Werb
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 2.  Drug therapy for obesity in the elderly.

Authors:  R Dvorak; R D Starling; J Callés-Escandon; E A Sims; E T Poehlman
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

Review 3.  Outcomes of pharmacological and surgical treatment for obesity.

Authors:  J Cerulli; M Malone
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

4.  Psychiatric disorders among obese patients seeking bariatric surgery: results of structured clinical interviews.

Authors:  Leorides Severo Duarte-Guerra; Bruno Mendonça Coêlho; Marco Aurélio Santo; Yuan-Pang Wang
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

5.  Sleep Disturbance in Bipolar Disorder Across the Lifespan.

Authors:  Allison G Harvey; Lisa S Talbot; Anda Gershon
Journal:  Clin Psychol (New York)       Date:  2009-06

Review 6.  The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach.

Authors:  Peter Hertzman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 7.  Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.

Authors:  A G Tsai; D F Williamson; H A Glick
Journal:  Obes Rev       Date:  2011-01       Impact factor: 9.213

Review 8.  Energy metabolism, fuel selection and body weight regulation.

Authors:  J Galgani; E Ravussin
Journal:  Int J Obes (Lond)       Date:  2008-12       Impact factor: 5.095

9.  Microlaparoscopic-assisted vaginal hysterectomy in the morbidly obese patient.

Authors:  Oscar D Almeida
Journal:  JSLS       Date:  2004 Jul-Sep       Impact factor: 2.172

10.  A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development.

Authors:  Kevin S Jones; Alexander P Alimov; Horacio L Rilo; Ronald J Jandacek; Laura A Woollett; W Todd Penberthy
Journal:  Nutr Metab (Lond)       Date:  2008-08-27       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.